Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Abken

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Cell Death and Differentiation|February 9, 2006
Autocrine proliferating B cells are susceptible to terminal differentiation and apoptosisJ Fluck, S Schachtschneider, H Abken
Anticancer Research|January 1, 1990
Altered expression of proto-oncogenes in human lymphoid cells immortalized by transfection with extrachromosomal DNA of mouse L cellsH Abken, C Bützler, K Willecke
Anticancer Research|July 1, 1987
Adenovirus type 5 persisting in human lymphocytes is unlikely to be involved in immortalization of lymphoid cells by fusion with cytoplasts or by transfection with DNA of mouse L cellsH Abken, C Bützler, K Willecke
Current Molecular Medicine|November 3, 2012
The weal and woe of costimulation in the adoptive therapy of cancer with chimeric antigen receptor (CAR)-redirected T cellsA A Hombach, A Holzinger, H Abken
Gene Therapy|October 15, 2010
CD28 cosignalling does not affect the activation threshold in a chimeric antigen receptor-redirected T-cell attackM Chmielewski, A A Hombach, H Abken
European Journal of Cell Biology|October 1, 1994
Tumorigenic transformation of established murine fibroblasts by transfection with amplification promoting DNA elementsH Abken, F Grummt, U H Weidle
Gene Therapy|June 18, 2010
Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc 'spacer' domain in the extracellular moiety of chimeric antigen receptors avoids 'off-target' activation and unintended initiation of an innate immune responseA Hombach, A A Hombach, H Abken
Hybridoma|April 22, 1999
Grafting T cells with tumor specificity: the chimeric receptor strategy for use in immunotherapy of malignant diseasesA Hombach, C Pohl, U Reinhold, et al.
Immunology|November 1, 1996
CD7-negative T cells represent a separate differentiation pathway in a subset of post-thymic helper T cellsU Reinhold, L Liu, J Sesterhenn, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993
Short DNA sequences from the cytoplasm of mouse tumor cells induce immortalization of human lymphocytes in vitroH Abken, R Hegger, C Bützler, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Cell Death and Differentiation|February 9, 2006
Autocrine proliferating B cells are susceptible to terminal differentiation and apoptosisJ Fluck, S Schachtschneider, H Abken
Anticancer Research|January 1, 1990
Altered expression of proto-oncogenes in human lymphoid cells immortalized by transfection with extrachromosomal DNA of mouse L cellsH Abken, C Bützler, K Willecke
Anticancer Research|July 1, 1987
Adenovirus type 5 persisting in human lymphocytes is unlikely to be involved in immortalization of lymphoid cells by fusion with cytoplasts or by transfection with DNA of mouse L cellsH Abken, C Bützler, K Willecke
Current Molecular Medicine|November 3, 2012
The weal and woe of costimulation in the adoptive therapy of cancer with chimeric antigen receptor (CAR)-redirected T cellsA A Hombach, A Holzinger, H Abken
Gene Therapy|October 15, 2010
CD28 cosignalling does not affect the activation threshold in a chimeric antigen receptor-redirected T-cell attackM Chmielewski, A A Hombach, H Abken
European Journal of Cell Biology|October 1, 1994
Tumorigenic transformation of established murine fibroblasts by transfection with amplification promoting DNA elementsH Abken, F Grummt, U H Weidle
Gene Therapy|June 18, 2010
Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc 'spacer' domain in the extracellular moiety of chimeric antigen receptors avoids 'off-target' activation and unintended initiation of an innate immune responseA Hombach, A A Hombach, H Abken
Hybridoma|April 22, 1999
Grafting T cells with tumor specificity: the chimeric receptor strategy for use in immunotherapy of malignant diseasesA Hombach, C Pohl, U Reinhold, et al.
Immunology|November 1, 1996
CD7-negative T cells represent a separate differentiation pathway in a subset of post-thymic helper T cellsU Reinhold, L Liu, J Sesterhenn, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993
Short DNA sequences from the cytoplasm of mouse tumor cells induce immortalization of human lymphocytes in vitroH Abken, R Hegger, C Bützler, et al.
Pageof 7